Goldfarb Branham LLP is investigating whether the Clarient, Inc. (NASDAQ:CLRT) Board of Directors breached fiduciary duties to shareholders in connection with the proposed acquisition of the company by GE Healthcare. If you are a Clarient shareholder you are encouraged to contact securities lawyer Hamilton Lindley at 877-583-2855 or firstname.lastname@example.org.
“Clarient will be acquired by GE Healthcare for $5.00 per share in cash,” said securities lawyer Hamilton Lindley. “However, at least one analyst has set a price target of $6.00 per share for Clarient stock. Our proposed class action lawsuit seeks to maximize the money and information that shareholders can receive under this transaction.”
Goldfarb Branham LLP has significant experience representing investors, at no cost to them, in securities lawsuits nationwide. Firm lawyers have been lead counsel on major securities lawsuits, including some of the largest transactions in the world and shareholder litigation stemming from the BP oil spill. Contact Hamilton Lindley at 877-583-2855 or